Clinical trials
Phase 3 Diabetes Mellitus trials in Estonia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 2 |
| Takeda | 2 |
| AstraZeneca | 1 |
| Diamyd Medical AB | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Janssen Research & Development, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 9 |
| Diabetes Mellitus, Type 2 | 6 |
| Diabetes Mellitus, Type 1 | 2 |
| Dyslipidemias | 2 |
| Glucose Metabolism Disorders | 2 |
| Autoimmune Diseases | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus, Lipoatrophic | 1 |
| Diabetic Neuropathies | 1 |
| Immune System Diseases | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.